According to a 7.5 year study by Dr. Simon Thomson et al., satisfaction with SCS was high with 92% of patients stating that they would have it all done again for the same result. Further, 96.4% of patients would have wanted SCS as a treatment option earlier!
So, why do we still resort to opioids?
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.